Skip to main content
. 2022 Mar 1;14(5):1279. doi: 10.3390/cancers14051279

Figure 3.

Figure 3

Correlation of CK20 in bone marrow and DEFA5 in blood with cumulative overall survival in esophageal carcinoma (EC) patients without neoadjuvant chemotherapy. (A) CK20 expression in bone marrow samples (BM) (n = 65) and (B) DEFA5 expression in blood samples (n = 98) of EC patients being therapy-naive before surgery was assessed by RT-PCR and correlated with overall survival by Kaplan–Meier analysis. On the vertical dotted line, the 5-year (60 months) overall survival is shown. The horizontal dotted line at the cumulative survival probability of 0.5 indicates the median survival. (BL: blood, BM: bone marrow).